Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of California, San Diego
La Jolla, California
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 218
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Karl Hostetler | Conflict of Interest | Antiva Biosciences, Inc. | >$600,000 | 2017 |
| Nigel Calcutt | Conflict of Interest | WinSanTor, Inc. | >$600,000 | 2017 |
| Michael Sailor | Conflict of Interest | Spinnaker Biosciences, Inc. | >$600,000 | 2017 |
| Kun Zhang | Conflict of Interest | Singlera Genomics, Inc. | >$600,000 | 2017 |
| Vipin Kumar | Conflict of Interest | GlycoregImmune, Inc. | >$600,000 | 2017 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | >$600,000 | 2017 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | >$600,000 | 2018 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | >$600,000 | 2017 |
| Pam Taub | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 | 2017 |
| Jeffrey Esko | Conflict of Interest | Tega Therapeutics | $500,000 - $549,999 | 2017 |
| Pam Taub | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 | 2015 |
| Francisco Villarreal | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 | 2017 |
| Francisco Villarreal | Conflict of Interest | Cardero Therapeutics | $500,000 - $549,999 | 2015 |
| Rommie Amaro | Conflict of Interest | Actavalon | $350,000 - $399,999 | 2015 |
| Rommie Amaro | Conflict of Interest | Actavalon, Inc. | $350,000 - $399,999 | 2015 |
| Alysson Muotri | Conflict of Interest | Tismoo | $250,000 - $299,999 | 2018 |
| Alysson Muotri | Conflict of Interest | Tismoo | $250,000 - $299,999 | 2018 |
| Alysson Muotri | Conflict of Interest | Tismoo | $250,000 - $299,999 | 2018 |
| Allen Ryan | Conflict of Interest | Otonomy, Inc. | $150,000 - $199,999 | 2017 |
| Eugene Yeo | Conflict of Interest | Locana, Inc | $150,000 - $199,999 | 2019 |
| Eugene Yeo | Conflict of Interest | Locana, Inc | $150,000 - $199,999 | 2019 |
| Joseph Witztum | Conflict of Interest | Isis Pharmaceuticals | $150,000 - $199,999 | 2015 |
| Allen Ryan | Conflict of Interest | Otonomy, Inc. | $150,000 - $199,999 | 2017 |
| Allen Ryan | Conflict of Interest | Otonomy, Inc. | $150,000 - $199,999 | 2017 |
| Joseph Witztum | Conflict of Interest | Isis Pharmaceuticals | $150,000 - $199,999 | 2015 |
| Eugene Yeo | Conflict of Interest | Locana, Inc | $100,000 - $149,999 | 2019 |
| Kun Zhang | Conflict of Interest | Singlera Genomics, Inc. | $100,000 - $149,999 | 2017 |
| Bradley Messmer | Conflict of Interest | Abreos Biosciences | $100,000 - $149,999 | 2015 |
| Eugene Yeo | Conflict of Interest | Locana, Inc | $100,000 - $149,999 | 2019 |
| Richard Gallo | Conflict of Interest | Sente | $100,000 - $149,999 | 2016 |
| Andrew McCulloch | Conflict of Interest | Insilicomed, Inc. | $60,000 - $79,999 | 2015 |
| Bradley Messmer | Conflict of Interest | Abreos Biosciences | $60,000 - $79,999 | 2015 |
| Andrew McCulloch | Conflict of Interest | Insilicomed, Inc. | $60,000 - $79,999 | 2015 |
| Paul Mills | Conflict of Interest | Chopra Foundation | $60,000 - $79,999 | 2016 |
| Andrew McCulloch | Conflict of Interest | Insilicomed, Inc. | $60,000 - $79,999 | 2015 |
| Karl Hostetler | Conflict of Interest | Antiva Biosciences, Inc. | $60,000 - $79,999 | 2017 |
| Andrew Sharabi | Conflict of Interest | Toragen, Inc. | $40,000 - $59,999 | 2019 |
| Steven Dowdy | Conflict of Interest | Solstice Biologics | $40,000 - $59,999 | 2017 |
| Joseph Pogliano | Conflict of Interest | Linnaeus Biosciences, Inc. | $40,000 - $59,999 | 2016 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | $40,000 - $59,999 | 2017 |
| Eric van Nostrand | Conflict of Interest | Eclipse BioInnovations | $40,000 - $59,999 | 2018 |
| Kit Pogaliano | Conflict of Interest | Linnaeus Biosciences, Inc. | $40,000 - $59,999 | 2016 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | $40,000 - $59,999 | 2017 |
| Karen Christman | Conflict of Interest | Ventrix, Inc. | $40,000 - $59,999 | 2018 |
| Allen Ryan | Conflict of Interest | Otonomy, Inc. | $20,000 - $39,999 | 2017 |
| Allen Ryan | Conflict of Interest | Otonomy, Inc. | $20,000 - $39,999 | 2017 |
| Richard Gallo | Conflict of Interest | Sente | $20,000 - $39,999 | 2016 |
| Stephanie Cherqui | Conflict of Interest | AVROBIO | $20,000 - $39,999 | 2018 |
| Kit Pogliano | Conflict of Interest | Linnaeus Bioscience, | $20,000 - $39,999 | 2015 |
| Joseph Pogliano | Conflict of Interest | Linnaeus Bioscience | $20,000 - $39,999 | 2015 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.